1-64880504-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002227.4(JAK1):​c.206-1356G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 152,020 control chromosomes in the GnomAD database, including 9,442 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9442 hom., cov: 32)

Consequence

JAK1
NM_002227.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.22

Publications

5 publications found
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
JAK1 Gene-Disease associations (from GenCC):
  • autoinflammation, immune dysregulation, and eosinophilia
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.448 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002227.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
NM_002227.4
MANE Select
c.206-1356G>A
intron
N/ANP_002218.2P23458
JAK1
NM_001320923.2
c.206-1356G>A
intron
N/ANP_001307852.1P23458
JAK1
NM_001321852.2
c.206-1356G>A
intron
N/ANP_001308781.1P23458

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
ENST00000342505.5
TSL:5 MANE Select
c.206-1356G>A
intron
N/AENSP00000343204.4P23458
JAK1
ENST00000671929.2
c.206-1356G>A
intron
N/AENSP00000500485.1P23458
JAK1
ENST00000671954.2
c.206-1356G>A
intron
N/AENSP00000500841.1P23458

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
51892
AN:
151906
Hom.:
9403
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.453
Gnomad AMI
AF:
0.188
Gnomad AMR
AF:
0.418
Gnomad ASJ
AF:
0.328
Gnomad EAS
AF:
0.306
Gnomad SAS
AF:
0.261
Gnomad FIN
AF:
0.296
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.276
Gnomad OTH
AF:
0.330
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.342
AC:
51992
AN:
152020
Hom.:
9442
Cov.:
32
AF XY:
0.343
AC XY:
25479
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.453
AC:
18768
AN:
41428
American (AMR)
AF:
0.419
AC:
6398
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
1136
AN:
3468
East Asian (EAS)
AF:
0.305
AC:
1575
AN:
5166
South Asian (SAS)
AF:
0.262
AC:
1263
AN:
4824
European-Finnish (FIN)
AF:
0.296
AC:
3122
AN:
10552
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.276
AC:
18779
AN:
67986
Other (OTH)
AF:
0.337
AC:
711
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1687
3374
5060
6747
8434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
504
1008
1512
2016
2520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.338
Hom.:
1182
Bravo
AF:
0.357
Asia WGS
AF:
0.316
AC:
1098
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.27
DANN
Benign
0.28
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2780831; hg19: chr1-65346187; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.